Position
Fidelity in Design Therapeutics, Inc.
Back to the book · All holders of DSGN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $2.97M$10.64 → $14.47
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 771.3K | $7.23M | — | — | — | 0.0% |
| Q1 2026 | 798.4K | $8.5M | $10.64 | $971.8K | $288.8K | 0.0% |
| Q2 2026 | 776.5K | $11.2M | $14.47 | $2.97M | −$233.5K | 0.0% |